IATI-Biomed 2015 Company Profile

01:27 EDT 23rd March 2018 | BioPortfolio

For the 14th consecutive year, IATI-Biomed is the largest and leading meeting place for healthcare professionals from Israel with international colleagues and partners. As such, this world-class event presents an opportunity for global participants to experience Israel’s life science innovation and vibrant biomedical industry at its best. Previous successful conferences hosted over 6,000 industry players, scientists and engineers including more than 1,000 attendees from over 45 countries that participated in over 4,500 one-on-one meetings. Hundreds of Israeli life science companies will present and exhibit their products, services and technologies allowing for hands-on experience. For more information, please visit

News Articles [193 Associated News Articles listed on BioPortfolio]

BioMed X and Roche announce research collaboration in the field of immunology

BioMed X announced the initiation of a new research collaboration with F. Hoffmann-La Roche Ltd in the field of immunology. Within the framework of the agreement, BioMed X will launch a global call fo...

BioMed X and Boehringer Ingelheim start new joint research group

BioMed X announced today the start of a new joint research group with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg. The focus of the group will be to identify novel regulatory ...

Q Biomed seeks FDA nod for new cancer bone pain drug facility

A regulatory filing was submitted to the FDA by Q BioMed for the approval of a new manufacturing facility that will produce S -More- 

Q BioMed, Washington Univ. team up in glaucoma

Washington University licensed Q BioMed Inc. an exclusive option to evaluate the growth differentiation factor 15 (GDF15) gene biomarker as a companion diagnostic with the MAN01 small molecule for gla...

THC BioMed Announces LOI to Acquire Farm and Greenhouses in Southern Ontario for Potential Cannabis Production - Video Available on

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2018) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHC), Canada's largest supplier of legal Cannabis Genetics, has entered into a Letter...

Q BioMed nets $5mm via FOPO

Specialty pharmaco Q BioMed Inc. netted $5mm through a follow-on public offering of 1.7mm common shares at $3.20. The company also issued 1.7mm five-year warrants to buy one share at an exercise price...

BeiGene to Generate New mAbs Using Harbour BioMed's Mouse Platform

Beijing's BeiGene licensed multi-year rights to use Harbour BioMed's H2L2 transgenic mouse platform, which generates fully human therapeutic monoclonal antibodies. Harbour BioMed, a Shanghai company, ...

THC BioMed's Subsidiary THC2GO Dispensers Submits Application to Operate Cannabis Retail Stores in Manitoba - Video Available on

Vancouver, British Columbia--(Newsfile Corp. - December 21, 2017) - THC BioMed's (CSE: THC) (OTCQB: THCBF) (FSE: TFHD) subsidiary, THC2GO Dispensers, has officially submitted its application to ope...

PubMed Articles [598 Associated PubMed Articles listed on BioPortfolio]

Trend of Socio-Demographic Index and Mortality Estimates in Iran and its Neighbors, 1990-2015; Findings of the Global Burden of Diseases 2015 Study.

The Global burden of disease and injuries study (GBD 2015) reports expected measures for years of life lost (YLL) based on socio-demographic index (SDI) of countries, as well as the observed measures....

QuickStats: Infant Mortality Rate, by Urbanization Level* - National Vital Statistics System, United States, 2007 and 2015.

In both 2007 and 2015, infant mortality rates were highest in rural counties (7.5 infant deaths per 1,000 live births and 6.8, respectively). Rates were lower in small and medium urban counties (7.1 i...

Corrigendum to "double sword role of EZH2 in leukemia" Biomed. Pharmacother. 98 (2018) 626-635.

The Role of Publishers in Prevention of Misconducts in Medical Research: Springer and BioMed Central, Victim or Culprit.

Erratum to "Automatic Segmentation of Ultrasound Tomography Image".

[This corrects the article DOI: 10.1155/2017/2059036.].

Clinical Trials [406 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

The aim of the study is to evaluate the safety and immunogenicity of the 2015-2016 formulations of Fluzone Quadrivalent and Fluzone Intradermal Quadrivalent vaccines in adults 18 to < 65 y...

Pumps for Kids, Infants, and Neonates

PumpKIN is a randomized, multicenter, two-arm trial evaluating the investigational Infant Jarvik 2015 versus the EXCOR® Pediatric VAD in pediatric patients with heart failure. This study ...

FINPOP 2015: Incidence, Methods, Complications and Quality of Life of Pelvic Organ Prolapse Operations in Finland 2015

The aim of this study is to investigate the safety and effectivity of pelvic organ prolapse (POP) surgery. In this multi center study the population consists of POP operations done in Finl...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Companies [201 Associated Companies listed on BioPortfolio]

IATI-Biomed 2015

For the 14th consecutive year, IATI-Biomed is the largest and leading meeting place for healthcare professionals from Israel with international colleagues and partners. As such...

IATI-BioMed Conference

IATI, run by CEO Karin Mayer Rubinstein is the largest umbrella organization representing the hi-tech and life sciences industries. With over 450 members, its mission is to streng...

IATI-BioMed Israel Conference 2013

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

More Information about "IATI-Biomed 2015" on BioPortfolio

We have published hundreds of IATI-Biomed 2015 news stories on BioPortfolio along with dozens of IATI-Biomed 2015 Clinical Trials and PubMed Articles about IATI-Biomed 2015 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IATI-Biomed 2015 Companies in our database. You can also find out about relevant IATI-Biomed 2015 Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record